NEUROPROTECTIVE EFFECT OF EPALRESTAT ON MEMORY IMPAIRMENT IN STREPTOZOTOCIN-INDUCED TYPE-2 DIABETIC RATS USING DIFFERENT BEHAVIORAL MODELS.
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i1.23313Keywords:
Type-2 diabetes, Epalrestat, Donepezil, Learning and memory, Morris water maze, Passive avoidance, Elevated plus maze, High-fat dietAbstract
 Objective: The present study was designed to evaluate the protective effects of epalrestat (EPS) on memory and learning in type-2 diabetes.
Methods: Sixty percent high-fat diet for 2 weeks and a single dose of streptozotocin (35 mg/kg, ip) was used to induce memory impairment in rats. Once the diabetes is confirmed, test drug (EPS - 13.5, 27, and 54 mg/kg, oral) and donepezil (1 mg/kg, oral) were administered to different groups of rats for 4 weeks followed by an assessment of memory and learning deficit using behavioral paradigms: Elevated plus maze (EPM), Morris water maze (MWM), and passive avoidance test.
Results: EPS and donepezil showed significant improvement in learning and memory of rats, as indicated by markedly decreased escape latency to reach a hidden platform and increased time spent in target quadrant using MWM task, reduced transfer latency in EPM, and also there is a significant increase in the transfer latencies using passive avoidance test were noted. Memory-enhancing activity of EPS (13.5, 27, and 54 mg/kg) was comparable with the diabetic control group.
Conclusion: The study findings suggest that memory-enhancing effect of EPS may be mediated by its antioxidant and anti-inflammatory activities. This recommends the potential effect of EPS therapy as a useful memory restorative agent in the treatment of neurodegenerative disease seen in type-2 diabetes rat.
Downloads
References
Reynolds RM, Strachan MW, Labad J, Lee AJ, Frier BM, Fowkes FG, et al. Morning cortisol levels and cognitive abilities in people with Type 2 diabetes: The Edinburgh Type 2 diabetes study. Diabetes Care 2010;33:714-20.
van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta 2009;1792:470-81.
Wrighten SA, Piroli GG, Grillo CA, Reagan LP. A look inside the diabetic brain: Contributors to diabetes-induced brain aging. Biochim Biophys Acta 2009;1792:444-53.
Vijayakumar TM, Sirisha GB, Begam F, Dhanaraju MD. Mechanism linking cognitive impairment and diabetes mellitus. Eur J Appl Sci 2012;4:1-5.
Greenwood CE, Winocur G. Learning and memory impairment in rats fed a high saturated fat diet. Behav Neural Biol 1990;53:74-87.
Eichenbaum H, Schoenbaum G, Young B, Bunsey M. Functional organization of the hippocampal memory system. Proc Natl Acad Sci U S A 1996;93:13500-7.
Bhutada P, Mundhada Y, Bansod K, Bhutada C, Tawari S, Dixit P, et al. Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats. Neurobiol Learn Mem 2010;94:293-302.
Bhutada P, Mundhada Y, Bansod K, Tawari S, Patil S, Dixit P, et al. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav Brain Res 2011;220:30-41.
Baydas G, Canatan H, Turkoglu A. Comparative analysis of the protective effects of melatonin and Vitamin E on streptozocin-induced diabetes mellitus. J Pineal Res 2002;32:225-30.
Hawkins CL, Davies MJ. Generation and propagation of radical reactions on proteins. Biochim Biophys Acta 2001;1504:196-219.
Hotta N, Sakamoto N, Shigeta Y, Kikkawa R, Goto Y. Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in japan: Multicenter study. Diabetic neuropathy study group in japan. J Diabetes Complications 1996;10:168-72.
Yama K, Sato K, Murao Y, Tatsunami R, Tampo Y. Epalrestat upregulates heme oxygenase-1, superoxide dismutase, and catalase in cells of the nervous system. Biol Pharm Bull 2016;39:1523-30.
Sato K, Yama K, Murao Y, Tatsunami R, Tampo Y. Epalrestat increases intracellular glutathione levels in schwann cells through transcription regulation. Redox Biol 2013;2:15-21.
Ohmura C, Watada H, Azuma K, Shimizu T, Kanazawa A, Ikeda F, et al. Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in Type 2 diabetes. Endocr J 2009;56:149-56.
Tripathi K D. Essentials of Medical Pharmacology. 6th ed. New Delhi: Jaypee Brothers medical Publishers; 2010. p. 99.
Sweetman SC. Martindale the Complete Drug Reference. 36th ed., Vol. 1. UK. RPS Publications; 2009. p. 439.
Yang Q, Kaji R, Takagi T, Kohara N, Murase N, Yamada Y, et al. Abnormal axonal inward rectifier in streptozocin-induced experimental diabetic neuropathy. Brain 2001;124:1149-55.
Mizuno K, Kato N, Makino M, Suzuki T, Shindo M. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy. J Diabetes Complications 1999;13:141-50.
Ghosh MN. Fundamentals of Experimental Pharmacology. 3rd ed. Kolkata: Hilton & Company; 2005.
Rahigude A, Bhutada P, Kaulaskar S, Aswar M, Otari K. Participation of antioxidant and cholinergic system in protective effect of naringenin against Type-2 diabetes-induced memory dysfunction in rats. Neuroscience 2012;226:62-72.
Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for Type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52:313-20.
Rajashree R, Kholkute SD, Goudar SS. Effects of duration of diabetes on behavioural and cognitive parameters in streptozotocin-induced juvenile diabetic rats. Malays J Med Sci 2011;18:26-31.
Rajashree R, Kholkute SD, Goudar SS. Effects of duration of diabetes on cognitive functions in streptozotocin induced young diabetic rats. Al Ameen J Med Sci 2012;5:256-63.
Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH, et al. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: Effects of insulin treatment. Brain Res 1998;800:125-35.
Sonkusare S, Srinivasan K, Kaul C, Ramarao P. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci 2005;77:1-4.
Amin SN, Younan SM, Oussef MF, Rashed LA, Mohamady I. Effect of diabetes mellitus on rat cognitive functions and related hippocampal synaptic plasticity markers. Med J Cairo Univ 2011;79:213-27.
Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of alzheimer disease and decline in cognitive function. Arch Neurol 2004;61:661-6.
Popoviç M, Biessels GJ, Isaacson RL, Gispen WH. Learning and memory in streptozotocin-induced diabetic rats in a novel spatial/object discrimination task. Behav Brain Res 2001;122:201-7.
Itoh J, Nabeshima T, Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice: Effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology (Berl) 1990;101:27-33.
Sharma AC, Kulkarni SK. Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:117-25.
Holmes CS, Hayford JT, Gonzalez JL, Weydert JA. A survey of cognitive functioning at difference glucose levels in diabetic persons. Diabetes Care 1983;6:180-5.
Kim B, Backus C, Oh S, Hayes JM, Feldman EL. Increased tau phosphorylation and cleavage in mouse models of Type 1 and Type 2 diabetes. Endocrinology 2009;150:5294-301.
Kucukatay V, Ağar A, Gumuslu S, Yargiçoğlu P. Effect of sulfur dioxide on active and passive avoidance in experimental diabetes mellitus: Relation to oxidant stress and antioxidant enzymes. Int J Neurosci 2007;117:1091-107.
Vangalapati B, Manjrekar PA, Hegde A, Kumar A. Pterocarpus marsupium heartwood extract restores learning, memory and cognitive flexibility in a STZ-NA induced diabetes animal model. Int J Pharm Pharm Sci 2016;8:339-43.
Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997;46 Suppl 2:S38-42.
Barnett PA, González RG, Chylack LT Jr., Cheng HM. The effect of oxidation on sorbitol pathway kinetics. Diabetes 1986;35:426-32.
Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, et al. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes 2003;52:864-71.
Gonzalez AM, Sochor M, Hothersall JS, McLean P. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens. Diabetes 1986;35:1200-5.
Yeh LA, Ashton MA. The increase in lipid peroxidation in diabetic rat lens can be reversed by oral sorbinil. Metabolism 1990;39:619-22.
Takebe G, Yarimizu J, Saito Y, Hayashi T, Nakamura H, Yodoi J, et al. A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. J Biol Chem 2002;277:41254-8.
Magaki S, Mueller C, Dickson C, Kirsch W. Increased production of inflammatory cytokines in mild cognitive impairment. Exp Gerontol 2007;42:233-40.
Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, et al. Systemic inflammation and disease progression in alzheimer disease. Neurology 2009;73:768-74.
Gourigari TR, Lepakshi BM, Kamsala RV, Raju RR. Evaluation of anticholinergic, antidiabetic and antioxidant activity of leaf extracts of Ochna obtusata DC using in vitro assays. Int J Pharm Pharm Sci 2016;8:82-7.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
